Cryno Overview
- Headquarters
- Ru
- Website
- cryno.bio
- Industry
- Biotechnology Research
- Employees
- 6
- Founded
- 2016
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Cryno
Cryno is developing a novel GLP-1 agonist for treatment and prevention of peripheral neuropathy and management of type 2 Diabetes and its complications.
Compare Similar Companies to Cryno
Gero
Biotechnology
Gray Matter
Biotechnology Research
Viva City
Government Administration
Alfa Chem
Pharmaceutical Manufacturing
Longevity Economics Institute
Biotechnology Research
OneFul Health Inc
Pharmaceutical Manufacturing
Phyteau, Inc.
Pharmaceutical Manufacturing
Synergic Bio Solutions
Biotechnology Research
Metabolytic Research
Biotechnology Research
MedMark USA
Pharmaceutical Manufacturing